Picture of Insight Molecular Diagnostics logo

IMDX — Insight Molecular Diagnostics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Oncocyte Reports Third Quarter 2022 Financial Results

Nov 10 (Reuters) - Oncocyte Corp  OCX.O :
    * ONCOCYTE REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
    * Q3 REVENUE $1.0 MILLION
    * QTRLY NET LOSS PER SHARE: BASIC AND DILUTED $0.08
    * Q3 EARNINGS PER SHARE VIEW $-0.11 -- REFINITIV IBES DATA
    * Q3 REVENUE VIEW $1.5 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX9TDZDJ 
Further company coverage:  OCX.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Insight Molecular Diagnostics

See all news